Latest News
Quidel’s Lyra® SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19; Also Receives CE Mark, Health Canada Authorization
Quidel Corporation (NASDAQ: QDEL) (“Quidel”) , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra® SARS-CoV-2 Assay has received expanded Emergency Use Authoriza...
Careers
Are you a determined, optimistic, team player? Quidel is looking for talented innovators who want to be part of revolutionizing medical diagnostics.
Support
To place orders, get assistance with shipments, pricing or contract administration view our Customer Support page.
Visit our Technical Support page to get help with product specifications, supporting docs or general support issues.
NEW: Register at MyQuidel.com to download and install the latest Software Updates, Assay and testing capabilities for your Quidel Instruments.